NCT07589387尚未招募不适用
Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 2,800
研究概览
简要总结
The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT that previously participated in the initial HTN Program.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aim 3 Inclusion Criteria:
- •Patients will be screened for diabetes with symptoms of hyperglycemia or BMI >25 kg/m2 and over the age of 18 years old. Upon first or previous diagnosis, diabetes patients will be registered.
- •Adults (≥18 years),
- •Patients with previous diabetes diagnosis
- •Patients with persistently elevated random glucose >200 mg/dl, fasting glucose >126 mg/dl, or hemoglobin A1c >6.5% on two or more occasions (when available)
- •Patients taking glucose lowering medications
- •Pregnant women are eligible for this program, or
- •Cognitively impaired adults are eligible for this program.
排除标准
- •- This program will not include any of the following special populations:
- •Individuals who are not yet adults (minors): i.e. infants, children, or teenagers <18 years old, or
- •Prisoners or other detained individuals.
研究者
Mark Huffman
Professor of Medicine and Global Health Center Co-Director
Washington University School of Medicine
相似试验
尚未招募
不适用
Hypertension Treatment in Nigeria 2.0NCT07351162Washington University School of Medicine10,000
尚未招募
4 期
A study to compare the efficacy of two antihypertensive medication given in combination versus single antihypertensive medication after increasing its dose.CTRI/2024/09/073749Dr Spandana80
尚未招募
不适用
The Impact of Mobile Application-Supported Monitoring on Treatment Compliance and Success in Lifestyle Changes in Hypertensive PatientsHypertensionNCT07299266University of Gaziantep40
尚未招募
2 期
Study of dietary pattern education to reduce homocysteine level and blood pressureCTRI/2025/02/079846Sikkim Manipal College of Nursing550
尚未招募
2 期
Athimathura Chooranam for High Blood PressureCTRI/2024/05/067698N RAKSHANA40